The move gives doctors and high-risk patients an additional option for treating mild-to-moderate illness caused by the coronavirus By Laurie McGinley, January 21, 2022 at 7:20 p.m. EST Federal regulators Friday approved the use of the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors...
Month: <span>January 2022</span>
Post
Orally Dissolving Buprenorphine Tied to Severe Tooth Decay, FDA Warns
January 13, 2022 Orally dissolving medications containing buprenorphine are linked to severe dental problems, including total tooth loss, the US Food and Drug Administration (FDA) warns in a safety communication. The oral side effects of these medications, which are used to treat opioid use disorder (OUD) and pain, include cavities/tooth decay, including rampant caries; dental abscesses/infection; tooth erosion; fillings...
Post
FDA Approves Combo Pill for Severe, Acute Pain
Megan Brooks October 19, 2021 The US Food and Drug Administration (FDA) has approved a combination pill containing celecoxib and tramadol (Seglentis) for the treatment of adults with acute pain severe enough to require an opioid analgesic and for which alternative treatments fail to provide adequate pain relief. Celecoxib is a nonsteroidal anti-inflammatory drug and tramadol is an opioid...
Post
Late-life exercise shows rejuvenating effects on cellular level
JANUARY 21, 2022 by University of Arkansas Credit: CC0 Public Domain For people who hate exercising, here comes some more bad news: it may also keep you younger. Not just looking younger, but actually younger, on an epigenetic level. By now, the benefits of exercise have been well established, including increased strength of bones and muscles,...
Post
Oral immunotherapy induces remission of peanut allergy in some young children
NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES IMAGE: PEANUTS IN A BOWL. CREDIT: NIAID A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth....
Post
Fewer breakthrough infections, lower hospitalization risk in Moderna vaccine recipients compared to Pfizer–BioNTech
JANUARY 20, 2022 by Case Western Reserve University Credit: CC0 Public Domain A new study by researchers at the Case Western Reserve University School of Medicine finds those who received the Moderna COVID-19 mRNA vaccine are less likely to experience “breakthrough” COVID-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine. A vaccine breakthrough infection occurs...
Post
PSMA PET validates EAU classification system to determine risk of prostate cancer recurrence
JANUARY 21, 2022 by Society of Nuclear Medicine and Molecular Imaging PET disease extent in EAU BCR low-risk patients, EAU BCR high-risk patients, and BCP patients (A) and predictors of PET M1 disease (B). OR = odds ratio. Credit: Justin Ferdinandus, Wolfgang P. Fendler, Andrea Farolfi, et al. New research has confirmed the accuracy of...
Post
Sinovac: Vaccine used in much of the world no match for Omicron variant
JANUARY 20, 2022 by Yale University Credit: Pixabay/CC0 Public Domain Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19. However, those vaccinations alone are of no help against the widely circulating Omicron variant, show a new...
Post
Fears that spin classes could be leading to women’s incontinence after exercise bikes are linked to a rise in pelvic problems
By DR PHILIPPA KAYE The patient, in her 50s, wasn’t so much embarrassed as perplexed. She had, in recent months, begun to suffer an inability to hold on when she had the urge to pee. Worse, she’d also begun to ‘leak’ a bit, almost without realising. She’d not suffered this kind of problem significantly after the...
Post
Pfizer, Moderna boosters up to 90% effective against Omicron: CDC
Three US studies offer more evidence that third dose of COVID vaccine is highly effective against Omicron. A healthcare worker receives a Pfizer COVID-19 booster shot in the United States [File: Lynne Sladky/AP]Published On 22 Jan 202222 Jan 2022 Booster shots of the Pfizer-BioNTech and Moderna vaccines have proven highly effective at preventing Omicron-related hospitalisations, according to...